The firm can now be reimbursed $355 for its microbe sequencing tests, which it said sets a competitive bar for other developers.
IDbyDNA Raises $20M in Series B Financing
The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.
Prescient Metabiomics, CoreBiome Developing Microbial Assay for Colon Cancer Screening
The companies are aiming to use microbial biomarkers to predict the development of precancerous adenomas and carcinomas.
uBiome Declares Bankruptcy, Offers Assets for Sale
The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.